Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy

References

• Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, et al. High-dose radiation improved local tumour control and overall survival in patients with inoperable/unresectable non-small cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005; 63: 324–33
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumours using an accelerator; clinical experience on the first thirty-one patients. Acta Oncol 1995; 34: 861–70
   PubMed Web of Science ®Google Scholar
• Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flientje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A non-invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004; 60: 186–96
   PubMed Web of Science ®Google Scholar
• Onishi H, Araki T, Shirato H., Nagata Y, Hiraoka M, Gomi K, et al. Stereotactic hypofractionated high-dose irradiation for stage I non small cell lung carcinoma. Cancer 2004; 101: 1623–31
   PubMed Web of Science ®Google Scholar
• Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005; 63: 1427–31
   PubMed Web of Science ®Google Scholar
• Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003; 124: 1946–55
   PubMed Web of Science ®Google Scholar
• Zimmermann FB, Geinitz H, Schill S, Thamm R, Nieder C, Schratzenstaller U, et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Proceedings of the 3rd Acta Oncologica Symposium on Stereotactic Body Radiotherapy, June 15-17, 2006, Copenhagen, Denmark. Acta Oncol 2006; 45: 771–994
   Google Scholar
• Van den Heuvel F. Decomposition analysis of differential dose volume histograms. Med Phys 2006; 33: 297–307
   PubMedGoogle Scholar
• Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to analytic function. Int J Radiat Oncol Biol Phys 1991; 21: 123–35
   PubMed Web of Science ®Google Scholar
• Willner J, Jost A, Baier K, Flentje M. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3D conformal radiotherapy. Strahlenther Onkol 2003; 179: 548–59
   PubMedGoogle Scholar
• Guckenberger M, Heilman K, Wulf J, Mueller G, Beckmann G, Flentje M. Pulmonary injury and tumour response after stereotactic body radiotherapy (SBRT): Results of a serial follow-up CT study. Radiother Oncol 2007; 85: 435–42
   PubMed Web of Science ®Google Scholar
• Kocak Z, Evans E, Zhou S, Miller KL, Folz RJ, Shafman TD, et al. Challenges in defining radiation pneumonitis in patients with lung cancer. Int J Radiat Oncol Biol Phys 2005; 62: 635–8
   PubMedGoogle Scholar
• Ohashi T, Takeda A, Shigematsu N, Kunieda E, Ishizaka A, Fukada J, et al. Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumours. Int J Radiat Oncol Biol Phys 2005; 62: 1003–8
   PubMedGoogle Scholar
• Paludan M, Traberg Hansen A, Petersen J, Grau C, Hoyer M. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency? Proceedings of the 3rd Acta Oncologica Symposium on Stereotactic Body Radiotherapy, June 15-17, 2006, Copenhagen, Denmark. Acta Oncol 2006; 45: 771–994
   Google Scholar
• Rodrigues G, Lock M, D'Souza D, Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer – a systematic review. Radiother Oncol 2004; 71: 127–38
   PubMed Web of Science ®Google Scholar
• Yorke ED, Jackson A, Rosenzsweig KE, Braban L, Leibel SA, Clifton Ling C. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2002; 54: 329–39
   PubMed Web of Science ®Google Scholar
• Hernando ML, Marks LB, Bentel JC, Zhou SM, Hollis D, Das SK, et al. Radiation induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001; 51: 650–9
   PubMed Web of Science ®Google Scholar
• Graham M, Purdy J, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999; 45: 323–9
   PubMed Web of Science ®Google Scholar
• Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 2003; 67: 275–83
   PubMed Web of Science ®Google Scholar
• Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC. Correlation of dosimetric factors and radiation pneumonitis for non-small cell lung cancer patients in a recently completed dose-escalation study. Int J Radiat Oncol Biol Phys 2005; 63: 672–82
   PubMed Web of Science ®Google Scholar
• Armstrong J, Raben A, Zelefsky M, Burt M, Leibel S, Burman C, et al. Promising survival with three dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 1997; 44: 17–22
   PubMedGoogle Scholar
• Marks LB. Dosimetric predictors of radiation-induced lung injury. Int J Radiat Oncol Biol Phys 2002; 54: 340–7
   PubMedGoogle Scholar
• Song DY, Benedict SH, Cardinale RM, Chung TD, Chang MG, Schmidt-Ullrich RK. Stereotactic body radiation therapy of lung tumours: Preliminary experience using normal tissue complication probability-based dose limits. Am J Clin Oncol 2005; 28: 591–6
   PubMed Web of Science ®Google Scholar
• Kontrisova K, Stock M, Dieckmann K, Bogner J, Potter R, Georg D. Dosimetric comparison of stereotactic body radiotherapy in different respiration conditions: A modelling study. Radiother Oncol 2006; 81: 97–104
   PubMed Web of Science ®Google Scholar